Several anti-Hep C antibody screening test kits have been licensed
or approved by the FDA for clinical use in the United States.

The more popular testing options are:
Abbott HCV EIA 2.0 - enzyme immunoassay (EIA)
ORTHO® HCV Version 3.0 ELISA - enzyme immunoassay (EIA)
OraQuick® HCV Rapid Antibody Test - rapid immunoassay
VITROS® Anti-HCV assay - immunometric assay

In 2011, the FDA granted a waiver under the
Clinical Laboratory Improvement Amendments
of 1988 ("CLIA") for the OraQuick® HCV Rapid
Antibody Test for use with fingerstick whole blood
and venous whole blood specimens to test persons who are at risk for hepatitis C. With this waiver, the OraQuick® HCV test now can be used by more than 180,000 sites in the United States including facilities that can perform CLIA-waived tests, such as outreach clinics, community-based organizations and physician offices. The test, which utilizes the OraQuick┬« technology platform, provides results in 20 minutes.